financetom
Business
financetom
/
Business
/
United Capital Financial Advisors Acquires Apexium Financial LP
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Capital Financial Advisors Acquires Apexium Financial LP
Nov 10, 2025 9:19 AM

IRVING, Texas, Nov. 10, 2025 /PRNewswire/ -- United Capital Financial Advisors, an established registered investment advisor (RIA), today announced the acquisition of Apexium Financial LP (Apexium Financial), a nationwide RIA with offices strategically located in the Northeast, Mid-Atlantic and Southwest.

This acquisition adds over $4 billion in assets under management (AUM) to United Capital, along with a team of seasoned professionals with more than 20 years of wealth management experience.

"We are excited to have Apexium Financial join United Capital," said Jim Rivers, President of United Capital. "Matt, Cory, Rob and the team have built a successful firm with a strong record of growth through multiple referral channels. United Capital and Apexium Financial share a focus on growth, client service and a financial planning-led approach. We are excited to help power and support the Apexium Financial team's continued success."

"The decision to join United Capital was driven by our shared goal of providing a more personalized approach for our clients' financial strategies," said the Apexium Managing Partners in a joint statement.  "Together, we can continue to provide exceptional service to our clients while capitalizing on United Capital's suite of in-house wealth management offerings, which includes estate planning, income tax planning, investment services, business-specific services and insurance."

Sidley Austin LLP served as Apexium's legal counsel and Decerno Advisors acted as M&A advisor. Apexium Financial is United Capital's second acquisition this year, following The Paul Group in September 2025.

About United Capital

United Capital Financial Advisors is an independent wealth management firm that employs a personalized planning process and proprietary investing strategies to build client portfolios. For more information, visit www.unitedcapitalwealth.com.

Media contact: [email protected]

View original content:https://www.prnewswire.com/news-releases/united-capital-financial-advisors-acquires-apexium-financial-lp-302609557.html

SOURCE United Capital Financial Advisors

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Nov 4, 2025
MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( PPCB ) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV)....
Molson Coors Beverage Q3 Non-GAAP Earnings, Net Sales Decline
Molson Coors Beverage Q3 Non-GAAP Earnings, Net Sales Decline
Nov 4, 2025
06:58 AM EST, 11/04/2025 (MT Newswires) -- Molson Coors Beverage ( TAP/A ) reported Q3 non-GAAP earnings Tuesday of $1.67 per diluted share, up/down from $1.80 a year earlier. Analysts polled by FactSet expected $1.69. Net sales for the quarter ended Sept. 30 were $2.97 billion, down from $3.04 billion a year earlier. Analysts surveyed by FactSet expected $3.01 billion....
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Nov 4, 2025
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 SOLANA BEACH, Calif., and VERO BEACH, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. ( EVOK ) (“Evoke”), a specialty pharmaceutical company focused primarily...
PJT Partners Q3 revenue up 37%, beats estimates
PJT Partners Q3 revenue up 37%, beats estimates
Nov 4, 2025
Overview * PJT Partners ( PJT ) Q3 revenue grows 37% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong financial performance * Company repurchased 2.3 mln shares, indicating confidence in future growth Result Drivers * STRATEGIC ADVISORY - Increase in strategic advisory revenues drove higher Q3 revenue * FUND PLACEMENT - Increase in fund placement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved